Conviction
$ Value
$14K
Shares
7,730
Price
$2
Filed
May 15
▶ Why this score? (9/10)
- ✓ Open market buy (+3)
- ✓ % of holdings >= 20% (+2)
- ✓ Director (+1)
- ✓ Cluster: 3 insiders buying (+2)
- ✓ Not a 10b5-1 plan (+1)
Insider
Name
Kim Christopher
Title
Chairman and CMO
CIK
0002040022
Roles
Transaction Details
Transaction Date
2025-05-14
Code
P
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
27,500
Footnotes
The price reported in Column 4 is a weighted average price. The reporting person undertakes to provide to Apimeds Pharmaceuticals US, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnotes (2)-(3) to this Form 4. | These shares were sold in multiple transactions at prices ranging from $1.75 to $1.86, inclusive. | These shares were sold in multiple transactions at prices ranging from $1.84 to $1.89, inclusive.